ChristinaMDordingMD
Psychiatry • Boston, MA"Staff Psychiatrist, Depression Clinical and Research Program Director of Sexual Behavior Studies, Depression Clinical and Research Program Assistant Professor of Psychiatry, Harvard Medical School "
Are you Dr. Dording?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 27 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
Dcrp 50 Stanford Street
4th Floor
Boston, MA 02114Phone+1 617-724-9457
Summary
- Dr. Christina Dording, MD is a board certified psychiatrist in Boston, Massachusetts. She is currently licensed to practice medicine in Massachusetts and Vermont. She is affiliated with Beverly Hospital and is a "Staff Psychiatrist at Depression Clinical and Research Program Assistant Professor of Psychiatry.
Education & Training
UMass Chan Medical SchoolResidency, Psychiatry, 1996 - 2000
Tufts University School of MedicineClass of 1990
Certifications & Licensure
MA State Medical License 1999 - 2026
VT State Medical License 1991 - 1992- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Safety and Effectiveness Study of Maca Root to Treat Antidepressant-Induced Sexual Dysfunction Start of enrollment: 2007 Dec 01
- Study of Maca Root for the Treatment of Antidepressant-Induced Sexual Dysfunction in Females Start of enrollment: 2007 Dec 27
- Study of Maca Root to Treat Sexual Dysfunction Associated With the Treatment Regimen for Bipolar Disorder in Females Start of enrollment: 2008 Feb 26
Publications & Presentations
PubMed
- 78 citationsKetamine augmentation for outpatients with treatment-resistant depression: Preliminary evidence for two-step intravenous dose escalation:Cristina Cusin, Dawn F. Ionescu, Kara J. Pavone, Oluwaseun Akeju, Paolo Cassano
The Australian and New Zealand Journal of Psychiatry. 2017-01-01 - 106 citationsRepeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial.Dawn F. Ionescu, Kate H. Bentley, Matthias Eikermann, Norman E. Taylor, Oluwaseun Akeju
Journal of Affective Disorders. 2019-01-15 - 63 citationsA double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorder.David Mischoulon, Catherine Best-Popescu, Michael Laposata, Wendelien Merens, Jessica L. Murakami
European Neuropsychopharmacology. 2008-09-01
